1. 6C.01: CULLIN-3 MUTATIONS LEADING TO SKIPPING OF EXON 9 ARE RESPONSIBLE FOR SEVERE CASES OF FAMILIAL HYPERKALAEMIC HYPERTENSION. (June 2015) Authors: Picard, H. Louis Dit; Latreche, S.; Thurairajasingam, N.; Auzan, C.; Fiquet, B.; Frayssinet, R.; Garnier, A.; Jendruchova, V.; Lobbedez, T.; Martorell, L.; Mortier, G.; Pela, I.; Taque, S.; Vargas-Poussou, R.; Clauser, E.; Jeunemaitre, X. Journal: Journal of hypertension Issue: Volume 33(2015)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. [OP.LB01.09] PREDICTION OF CV EVENT IN DIABETIC NEPHROPATHY. (September 2016) Authors: Fauvel, J.; Joly, D.; Choukroun, G.; Dussol, B.; Fiquet, B.; Halimi, J.-M.; Quere, S.; Combe, C.; Ducher, M. Journal: Journal of hypertension Issue: Volume 34:(2016) Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. FEASIBILITY OF ESTIMATING FIBROMUSCULAR DYSPLASIA PREVALENCE USING HEALTH ADMINISTRATIVE DATABASE: A NATIONWIDE STUDY. (June 2018) Authors: Looten, V.; Chatellier, G.; Jantzen, R.; Fiquet, B.; Chedid, A.; Amar, L.; Bobrie, G.; Katsahian, S.; Burgun, A.; Jannot, A.S.; Jeunemaitre, X.; Plouin, P.-F.; Azizi, M. Journal: Journal of hypertension Issue: Volume 36(2018)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Which oral antidiabetic drug to combine with metformin to minimize the risk of hypoglycemia when initiating basal insulin?: A randomized controlled trial of a DPP4 inhibitor versus insulin secretagogues. (June 2016) Authors: Gautier, J.F.; Monguillon, P.; Verier-Mine, O.; Valensi, P.; Fiquet, B.; Dejager, S.; Charbonnel, B. Journal: Diabetes research and clinical practice Issue: Volume 116(2016) Page Start: 26 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗